Published in Ann Intern Med on June 15, 1992
Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis (2007) 5.21
Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis (2011) 1.66
Concurrent occurrence of Sweet's syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatoses. Clin Rheumatol (2005) 1.52
Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol (1999) 1.02
Sweet syndrome and its association with hematopoietic neoplasms. Proc (Bayl Univ Med Cent) (2015) 0.82
Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Korean J Intern Med (2001) 0.76
The Sweet syndrome or G-CSF reaction? Ann Intern Med (1992) 0.75
Proton pump inhibitor-induced Sweet's syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer. Dermatol Pract Concept (2015) 0.75
Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol (2016) 0.75
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest (1990) 3.74
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest (1994) 3.49
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest (1997) 2.57
Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation (1997) 2.26
Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes (1992) 2.16
HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care (2001) 1.99
Vascular function, insulin resistance and fatty acids. Diabetologia (2002) 1.97
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol (1999) 1.92
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest (1998) 1.82
Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest (1996) 1.72
Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes (2000) 1.71
Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab (2001) 1.71
Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal. J Urol (1997) 1.63
Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes (2000) 1.59
Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. Am J Physiol (1991) 1.50
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care (1999) 1.46
Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation. Ann Surg Oncol (1999) 1.42
Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation (2001) 1.34
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer (2005) 1.34
Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation (2000) 1.32
Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest (1985) 1.32
Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. J Gen Intern Med (1987) 1.30
Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes (1987) 1.27
Impaired glucose tolerance. Why is it not a disease? Diabetes Care (1999) 1.18
Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. Biochemistry (1997) 1.16
Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care (1997) 1.15
Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile. Mod Pathol (1996) 1.10
Insulin-mediated vasodilation: why one's physiology could be the other's pharmacology. Diabetologia (1999) 1.10
Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol (1990) 1.08
Derivation of the Secondary Structure of the ITS-1 Transcript in Volvocales and its Taxonomic Correlations. Protist (2009) 1.04
Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study. Colorectal Dis (2007) 1.03
Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer. Ann Oncol (2008) 0.97
Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes (1990) 0.96
Hepatocellular carcinoma. Curr Opin Oncol (2000) 0.96
Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse. Metabolism (1999) 0.96
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. Br J Cancer (2013) 0.94
Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow. Am J Physiol (1992) 0.92
Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol (1987) 0.92
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates. Ann Oncol (2013) 0.91
Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes (1999) 0.91
Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J Clin Endocrinol Metab (1995) 0.90
Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus. Metabolism (1998) 0.89
Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes (1990) 0.89
Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes. Horm Metab Res (2005) 0.88
Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest (1998) 0.87
Ultradian variations of chromogranin A in humans. Am J Physiol (1991) 0.86
Intravenous gammglobulin-associated acute renal failure. Am J Hematol (2001) 0.86
Ethanol-induced neutrophil apoptosis is mediated through nitric oxide. J Leukoc Biol (1999) 0.84
Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst (1991) 0.83
Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies. J Clin Endocrinol Metab (1991) 0.83
Endothelial function, insulin sensitivity, and hypertension. Circulation (1997) 0.83
In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine. J Clin Endocrinol Metab (1987) 0.81
Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction. Ann Oncol (1998) 0.79
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease. Cancer (1993) 0.78
Hepatic intra-arterial methylene blue injection during endoscopy: a method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump. Gastrointest Endosc (1992) 0.78
Heparin-induced endothelial cell cytoskeletal reorganization: a potential mechanism for vascular relaxation. Kidney Int (1995) 0.78
The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics. Metabolism (1987) 0.78
Lack of relationship between muscle sympathetic nerve activity and skeletal muscle vasodilation in response to insulin infusion. Diabetologia (1996) 0.76
Insulin-dependent diabetes mellitus and nitrovasodilation. Important and complex interactions. Circulation (1997) 0.76
Activity of coumarin and cimetidine in metastatic renal cell carcinoma. J Clin Oncol (1989) 0.76
Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med (2000) 0.75
Pentoxifylline and aplastic anemia. Ann Intern Med (1987) 0.75
Rosai Dorfman disease--a clinico-pathological presentation. J Assoc Physicians India (2007) 0.75
Occurrence of Bezold-Jarisch reflex during hyperinsulinemic glucose clamp. Diabetes Care (1992) 0.75
Influence of sample temperature on reflectance photometry and electrochemical glucometer measurements. Diabetes Care (1996) 0.75
A TFE3+ gastrointestinal tumour: report of a case. Histopathology (2006) 0.75
Magnesium deficiency enhances basal glucose disposal in the rat. Am J Physiol (1995) 0.75
Elevated plasma tamoxifen levels in a patient with liver obstruction. Cancer Chemother Pharmacol (1989) 0.75
Rapid purification of reporter group-tagged inositol hexakisphosphate on ion-exchange membrane adsorbers. Biotechniques (1997) 0.75
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. Cancer (1993) 0.75
Glucose and amino acid turnover in untreated gestational diabetes. Diabetes Care (1996) 0.75
Somatostatin does not increase insulin-stimulated glucose uptake in humans. Diabetes (1987) 0.75
Prophylactic heparin in APL. Blood (1987) 0.75